Authors: J. Štolfa Authors‘ workplace: Revmatologický ústav, Praha Published in: Čes. Revmatol., , 2000, No. 2, p. 67-71. Category:
The objective of this open postmarketing study is to test and express objectively the effectivenessand tolerance of meloxicam in active rheumatoid arthritis in clinical practice of out-patientrheumatologists in the Czech Republic. A total of 412 patients (76 men, 336 women) participated inthe study, mean age 53.1 (± 7) years, suffering from active rheumatoid arthritis on an average for8.6 years (± 4.3). The study lasted 8 weeks and the administered dose of meloxicam dose was 15–7.5mg per dose. At the end of the study a statistically significant improvement of all investigatedparameters of effectiveness was recorded: mean painfulness of joints at rest (p
Key words: meloxicam, rheumatoid arthritis
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
